Enovis (ENOV) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Enovis (ENOV) is Moderate Underperform.

The composite score behind that read is -0.27, weighing +0.16 of bullish evidence against -0.38 bearish.

Enovis last closed at $18.69, +5.18% on the session.

Against the IVW growth benchmark the position is +4.26% over the forecast window.

The read is built from 11 underlying insights — 2 bullish and 9 bearish.

Agreement across those insights is 82%.

16 graded predictions for ENOV so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Enovis in the 15th percentile on return on equity, where 100 is best.

Enovis is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $1.02B.

StockMap tracks Enovis as the 59th largest of the 133 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 67 Neutral, 61 Moderate Underperform, 4 Strong Underperform and 1 Moderate Outperform.

On that composite Enovis ranks 92nd of 133 in the group, against a group median of -0.21.